Monographie - Argatroban - Stabilis 4.0

Son güncelleme :
19/11/2024

Antikoagülan

Argatroban

Enjeksiyon

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Kimyasal yapı

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Arganova	Fransa, İspanya
Argatra	Almanya, İsviçre, Slovenya
Argatroban	Almanya, Amerika Birleşik Devletleri, Büyük Britanya, Kanada
Exembol	Büyük Britanya
Novastan	Danimarka, Finlandiya, İsveç, Japonya, Norveç

Kaynaklar

Enjeksiyon

Kaynaklar : Argatroban

	tip	yayın
1963	Dergi	Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. Compatibility of argatroban with selected cardiovascular agents. Am J Health-Syst Pharm 2004 ; 61: 2415-2418.
1964	Dergi	Hartman CA, Baroletti SA, Churchill WW et al. Visual compatibility of argatroban with selected drugs. Am J Health-Syst Pharm 2002 ; 59: 1784-1785.
2004	Dergi	Patel K, Hursting MJ. Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
2277	Laboratuar	Argatroban - Summary of Product Characteristics GlaxoSmithKline 2008
3235	afiş	Klemmer A, Krämer I. Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen. ADKA Congress 2011 2011
3295	Laboratuar	Argatroban - Résumé Caractéristiques du Produit LFB Biom?dicaments 2018
3764	Dergi	Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S. Compatibility of argatroban injection with select antiarrhythmic drugs Am J Health-Syst Pharm 2014 2014; 71: 1831-1832.

Mentions Légales